Biotinyl-Tau Peptide (306-336) (Repeat 3 Domain) (human) |
| Katalog-Nr.GA20848 |
The amphipathic helical structure of the third fragment (306-336), in the four-repeat microtubule-binding domain of tau, is hypothesized to be responsible for the formation of the neuropathological filament. The additional biotin moiety will bind avidin or streptavidin with high specificity and affinity, providing robust results.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2022956-58-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
The amphipathic helical structure of the third fragment (306-336), in the four-repeat microtubule-binding domain of tau, is hypothesized to be responsible for the formation of the neuropathological filament. The additional biotin moiety will bind avidi
Average Rating: 5 (Based on Reviews and 8 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *